Since its founding in 2007, the Melanoma Research Alliance has become the largest non-profit funder of melanoma research worldwide. Through over 480 awards, MRA has directly invested more than $160 million, and leveraged an additional $500 million in collaborative and follow-on funding towards its mission.
MRA is catalyzing strategic, collaborative, and accountable research efforts that have moved the field forward and given patients and their loved ones better treatment options and renewed hope.
See how MRA plans to address gaps in accurate detection and diagnosis; our understanding of how best to treat rare melanomas (acral, mucosal, uveal, and pediatric); and how to tackle treatment-resistant disease – especially brain metastasis and leptomeningeal disease.
MRA supports both individual investigator and collaborative team projects focused on translational, innovative research that will impact the prevention, diagnosis, staging, and treatment of melanoma in the near and intermediate future. Explore our vast portfolio of funded projects.
Each year, MRA selects new research awards to address critical unmet needs in melanoma detection, prognostication, and treatment. All grant awards are selected by MRA’s Grant Review Committee through a diligent peer review process and are confirmed by our Board of Directors.
MRA’s Annual Scientific Retreat is the premier annual convening of global thought leaders from across the melanoma research community.
The RARE Registry gives patients and family members the opportunity to help answer critical questions about acral & mucosal melanoma.
In an effort to facilitate and accelerate breakthroughs in melanoma, MRA has developed numerous resources to support researchers.
MRA has supported hundreds of principle investigators on more than 480 distinct research projects. Funded Investigators come from 160 institutions across 19 countries. Our research has looked at 225 unique therapeutic approaches, and has touched all 17 new treatments approved by the FDA since our founding.
Our Grant Mechanisms